Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 133 clinical trials
Featured trial
GPS: Adaptation Trial of an HIV Prevention Counselling Program for HIV-positive and HIV-negative Gay and Bisexual Men

GPS is a sexual health promotion and HIV prevention peer-delivered counselling program. The GPS program has 4 parts: information provision about HIV and sexually transmitted infections

motivational interviewing
AIDS
AIDS prevention
sexually transmitted disease
  • 885 views
  • 19 Sep, 2018
  • 4 locations
Featured trial
Adolescent BV - Impact of the vaginal microbiome on topical HIV pre-exposure prophylaxis (PrEP)

in young women that causes itching, odor, vaginal discharge, and inflammation. Women with BV may be at increased risk to become infected with sexually transmitted infections, including HIV. This is why

sexually transmitted infections
  • 210 views
  • 23 Nov, 2020
  • 1 location
Brief Intervention to Reduce STDs in ER Drug Users - 1

transmitted infections among emergency department patients who use heroin and cocaine and are out-of-treatment for their substance abuse.

motivational interviewing
heroin
  • 48 views
  • 07 Nov, 2020
  • 1 location
Opportunities Beyond the Narrative: An Intervention for Justice-Involved Youth

involvement in risky sexual behaviors, including teen pregnancy. The intervention shows potential to promote optimal health and reduce teen pregnancy and sexually transmitted infections (STIs) among

Accepts healthy volunteers
  • 26 views
  • 12 May, 2022
  • 1 location
A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population

This study aims to use a social media mini-application-enabled intervention to successfully promote the initiation and persistence of pre-exposure prophylaxis (PrEP) among at-risk men who have sex with men (MSM) and youth in Wuhan and Guangzhou, China.

Accepts healthy volunteers
  • 0 views
  • 10 Oct, 2021
  • 1 location
Localized mHealth Approach to Boosting COVID-19 Testing and Vaccine Literacy, Access, and Uptake Among Women With Criminal Legal System Involvement (COVID-19)

The objective of this research is to use a localized mHealth intervention to boost COVID-19 testing and vaccine literacy, access, and uptake among women with CLSI

Accepts healthy volunteers
  • 0 views
  • 25 Oct, 2022
  • 1 location
A Clinical Risk Score for Early Management of TB in Uganda (PredicTB)

Although curative treatment exists, tuberculosis (TB) remains the leading cause of infectious mortality worldwide - often because people seek care for TB symptoms in highly resource-constrained clinics that cannot provide same-day diagnostic testing. The research team has developed an easy-to-use clinical risk score that, if implemented in these settings, might …

  • 0 views
  • 21 Mar, 2022
  • 1 location
Evaluation of Momentary Affect Regulation - Safer Sex Intervention (MARSSI)

The purpose of the study is to determine the impact of the offer to participate in the Momentary Affect Regulation - Safer Sex Intervention (treatment) relative to the offer to participate in the control condition on participants' reported condom use, use of effective contraception, and number of sexual partners three …

  • 15 views
  • 15 Oct, 2022
  • 2 locations
A Randomized, Double-Blind, Placebo-Controlled, Phase I Clinical Study Evaluating the Safety of a Single Ascending Dose of STI-1558 in Healthy Subjects and the Safety, Pharmacokinetics, and Efficacy of Multiple Ascending Doses of STI-1558 in SARS-CoV-2-Positive Subjects

The purpose of this study is to evaluate the safety of STI-1558 in healthy subjects and the safety, pharmacokinetics, and efficacy in SARS-CoV-2-Positive subjects.

Accepts healthy volunteers
  • 0 views
  • 29 Oct, 2022
  • 1 location
A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

This is a Phase III Randomized, Controlled, Multicenter, Open-label Study of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients with Relapsed or

  • 0 views
  • 04 Oct, 2022
  • 28 locations